Clinical Adverse Events of High-Dose vs Low-Dose Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Meta-Analysis of 51 Randomized Clinical Trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works matching AU Fang-Hong Shi
Results: 22
1
2
Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00576
- By:
- Publication type:
- Article
3
Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With ABCB1 and CES-1 Genetic Defect.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00491
- By:
- Publication type:
- Article
4
High‐dose sodium‐glucose co‐transporter‐2 inhibitors are superior in type 2 diabetes: A meta‐analysis of randomized clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 9, p. 2125, doi. 10.1111/dom.14452
- By:
- Publication type:
- Article
5
The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians.
- Published in:
- Frontiers in Plant Science, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00756
- By:
- Publication type:
- Article
6
Influence and mechanism of sodium-glucose cotransporter-2 inhibitors on the cardiac function: study protocol for a prospective cohort study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1199960
- By:
- Publication type:
- Article
7
α<sub>4</sub>β<sub>7</sub> integrin inhibitors: a patent review.
- Published in:
- Expert Opinion on Therapeutic Patents, 2018, v. 28, n. 12, p. 903, doi. 10.1080/13543776.2018.1549227
- By:
- Publication type:
- Article
8
Intervention by clinical pharmacists can improve blood glucose fluctuation in patients with diabetes and acute myocardial infarction: A propensity score-matched analysis.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 2, p. 1, doi. 10.1002/prp2.725
- By:
- Publication type:
- Article
9
Evaluating the Overall Safety of Glucokinase Activators in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2024, v. 17, p. 4539, doi. 10.2147/DMSO.S474280
- By:
- Publication type:
- Article
10
The Importance of Clinical Pharmacists in Improving Blood Glucose and Lipid Levels in Patients with Diabetes and Myocardial Infarction.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2023, v. 16, p. 2733, doi. 10.2147/DMSO.S425960
- By:
- Publication type:
- Article
11
The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00756
- By:
- Publication type:
- Article
12
Breaking through diabetes management barriers: Assessing the accuracy of Freestyle Libre Pro flash continuous glucose monitoring in diabetes patients with myocardial infarction.
- Published in:
- Digital Health, 2024, p. 1, doi. 10.1177/20552076241287842
- By:
- Publication type:
- Article
13
Sodium-Glucose Co-Transporter 2 Inhibitors Use Improves the Satisfaction With Anti-diabetic Agent Treatment: A Questionnaire-based Propensity Score-matched Study.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.787704
- By:
- Publication type:
- Article
14
Efficacy and Safety of Ertugliflozin in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.752440
- By:
- Publication type:
- Article
15
Evaluating the overall renal outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with chronic kidney disease (CKD).
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
16
Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00635
- By:
- Publication type:
- Article
17
CPUY11018, an azimilide derivative, ameliorates isoproterenol-induced cardiac insufficiency through relieving dysfunctional mitochondria and endoplasmic reticulum.
- Published in:
- Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 8, p. 1029, doi. 10.1111/jphp.12401
- By:
- Publication type:
- Article
18
Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver.
- Published in:
- Journal of Pharmacy & Pharmacology, 2013, v. 65, n. 6, p. 916, doi. 10.1111/jphp.12051
- By:
- Publication type:
- Article
19
Appraisal of Non-Cardiovascular Safety for Sodium–Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01066
- By:
- Publication type:
- Article
20
The Management of Heavy Menstrual Bleeding After Percutaneous Coronary Intervention in a Woman of Reproductive Age.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
21
Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.977265
- By:
- Publication type:
- Article
22
Beneficial Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Left Ventricular Function.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 4, p. 1191, doi. 10.1210/clinem/dgab834
- By:
- Publication type:
- Article